Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the stock exchanges about its upcoming schedule of meetings with analysts and institutional investors. The company will participate in the Equirus Annual India Conference '25 on 19 August 2025 in Mumbai, followed by the Systematix Group Pharma & Healthcare Conference on 20 August 2025, also in Mumbai. Both meetings will be held in physical format and include group sessions as well as one-on-one interactions. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings. The schedule is subject to change due to unforeseen circumstances.
This is a routine investor engagement intimation with no material business update or price-sensitive disclosure. Stock price impact is expected to be neutral, as the company is simply communicating its participation in standard investor conferences.